Login / Signup
Kirsten De Ridder
ORCID
Publication Activity (10 Years)
Years Active: 2021-2022
Publications (10 Years): 2
Top Topics
Low Dose
Skin Cancer
Cell Proliferation
Vascular Endothelial Growth Factor
Top Venues
Molecular cancer therapeutics
International journal of molecular sciences
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Thomas Ertveldt
,
Lien De Beck
,
Kirsten De Ridder
,
Hanne Locy
,
Wout de Mey
,
Cleo Goyvaerts
,
Quentin Lecocq
,
Hannelore Ceuppens
,
Yannick De De Vlaeminck
,
Robin Maximilian Awad
,
Marleen Keyaerts
,
Nick Devoogdt
,
Matthias D'Huyvetter
,
Karine Breckpot
,
Ahmet Krasniqi
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model.
Molecular cancer therapeutics
21 (7) (2022)
Thomas Benoot
,
Elisa Piccioni
,
Kirsten De Ridder
,
Cleo Goyvaerts
TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?
International journal of molecular sciences
22 (16) (2021)